6505-01-370-7521 ( CIPRO I.V. , NDC00026-8566-65 , CIPRO , NDC00026-8566-65 )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-370-7521 6505 013707521 CIPROFLOXACIN CONCENTRATE FOR IN 4712
NSN Features
MRC Parameter Characteristics
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 1200.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY CIPROFLOXACIN CONCENTRATE FOR INJECTION 1200MG 120ML VIAL 6S
CQCT PRIMARY CONTAINER TYPE VIAL
CRLK PRIMARY CONTAINER CONTENT QUANTITY 120.000 MILLILITERS
CSCW TOTAL PRIMARY CONTAINER QUANTITY 6
FEAT SPECIAL FEATURES CONTAINS 1 PERCENT AQUEOUS CONCENTRATE OF CIPROFLOXACIN; FOR INTRAVENOUS USE
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
CIPRO I.V. 13521 A 1 5 4 KX
NDC00026-8566-65 06245 A 2 3 4 ZZ
CIPRO 13521 A 1 5 4 ZZ
NDC00026-8566-65 13521 A 9 5 4 KX
Manufacturers
Part SKU Cage Manufacturer Type Status
CIPRO I.V. 13521 BAYER PHARMACEUTICALS CORPORATIO A A
NDC00026-8566-65 06245 BAYER CO THE A A
CIPRO 13521 BAYER PHARMACEUTICALS CORPORATIO A A
NDC00026-8566-65 13521 BAYER PHARMACEUTICALS CORPORATIO A A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 01/30/1 P 3004200060 4712
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DS I K U/I CONTAINS 6 EA
DN 9B----- N K U/I CONTAINS 6 EA
DF ------- F K U/I CONTAINS 6 EA
DA C2201X- A K U/I CONTAINS 6 EA
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DN SMS L 1 PG M U 9B----- N
DA SMS L 1 PG M U C2201X- A
DS SMS L 1 PG M U D
DF SMS L 1 PG M U ------- F
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC